<DOC>
	<DOC>NCT00507806</DOC>
	<brief_summary>The study is designed to examine the safety, tolerability, and activity of a combination of microbubbles (perflutren lipid microsphere [DefinityÂ®]) and continuous monitoring with 2 MHz transcranial Doppler ultrasound (TCD) as an adjunctive therapy to tissue plasminogen activator (tPA) treatment in subjects with acute ischemic stroke.</brief_summary>
	<brief_title>Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>Measurable focal neurological deficit (National Institutes of Health Stroke Scale [NIHSS] score &gt; 4 points) tPA eligible Occlusion of the middle cerebral artery Right to left cardiac shunt Uncontrolled hypertension Absent temporal windows</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Acute Ischemic Stroke</keyword>
	<keyword>Microbubbles</keyword>
	<keyword>Transcranial Doppler ultrasound</keyword>
	<keyword>TIBI</keyword>
	<keyword>Symptomatic Intracranial Hemorrhage</keyword>
	<keyword>modified Rankin Scale</keyword>
	<keyword>Recanalization</keyword>
	<keyword>Perflutren</keyword>
</DOC>